213 related articles for article (PubMed ID: 3477409)
1. New synthetic quinolone antibacterial agents and serum concentration of theophylline.
Niki Y; Soejima R; Kawane H; Sumi M; Umeki S
Chest; 1987 Oct; 92(4):663-9. PubMed ID: 3477409
[TBL] [Abstract][Full Text] [Related]
2. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
Drugs; 1987; 34 Suppl 1():159-69. PubMed ID: 3481317
[TBL] [Abstract][Full Text] [Related]
3. The influence of the 4-quinolones ciprofloxacin, pefloxacin and ofloxacin on the elimination of theophylline.
Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S72-5. PubMed ID: 3481439
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
Wise R; Griggs D; Andrews JM
Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
[TBL] [Abstract][Full Text] [Related]
5. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Husson MO; Izard D; Bryskier A; Leclerc H
Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro studies with 4-quinolone antimicrobials.
Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
[TBL] [Abstract][Full Text] [Related]
7. [Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
Guenounou M; Ronco E; Kodari E; Vacheron F; Momrikof V
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):785-9. PubMed ID: 3309816
[TBL] [Abstract][Full Text] [Related]
8. 4-quinolones inhibit biotransformation of caffeine.
Harder S; Staib AH; Beer C; Papenburg A; Stille W; Shah PM
Eur J Clin Pharmacol; 1988; 35(6):651-6. PubMed ID: 2853056
[TBL] [Abstract][Full Text] [Related]
9. [In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].
Grimm H
Infection; 1986; 14 Suppl 3():S191-5. PubMed ID: 3093387
[TBL] [Abstract][Full Text] [Related]
10. The comparative pharmacokinetics of five quinolones.
Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.
Edlund C; Nord CE
Scand J Infect Dis; 1986; 18(2):149-51. PubMed ID: 2939556
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
[TBL] [Abstract][Full Text] [Related]
13. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Smith JT
Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of drug metabolism by quinolone antibiotics.
Edwards DJ; Bowles SK; Svensson CK; Rybak MJ
Clin Pharmacokinet; 1988 Sep; 15(3):194-204. PubMed ID: 3052987
[TBL] [Abstract][Full Text] [Related]
15. [Fluoroquinolones].
Baykal M; Akalin E
Mikrobiyol Bul; 1987 Apr; 21(2):151-7. PubMed ID: 3482120
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of ofloxacin on theophylline pharmacokinetics in rats.
Okazaki O; Miyazaki K; Tachizawa H
Chemotherapy; 1987; 33(6):402-11. PubMed ID: 3480792
[TBL] [Abstract][Full Text] [Related]
17. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Ridgway GL; O'Hare MD; Felmingham D; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(4):259-62. PubMed ID: 2941258
[TBL] [Abstract][Full Text] [Related]
18. Effects of quinolones on granulocyte function in vitro.
Boogaerts MA; Malbrain S; Scheers W; Verwilghen RL
Infection; 1986; 14 Suppl 4():S258-62. PubMed ID: 3469158
[TBL] [Abstract][Full Text] [Related]
19. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
Renaudin H; Quentin C; de Barbeyrac B; Bebear C
Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
[TBL] [Abstract][Full Text] [Related]
20. In-vitro selection of bacteria resistant to the 4-quinolone agents.
Limb DI; Dabbs DJ; Spencer RC
J Antimicrob Chemother; 1987 Jan; 19(1):65-71. PubMed ID: 3470281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
